Can a nurse check on you from home? new study tests remote monitoring for rare cancers
NCT ID NCT05500391
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether follow-up care for people with rare tumors can be done just as well by a nurse remotely as by a doctor in person. About 88 adults recently diagnosed with a rare tumor will be randomly assigned to either in-person doctor visits or remote nurse check-ins. The goal is to see how well patients stick to their personalized monitoring plans over two years.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOCARCINOMA, CLEAR CELL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Amiens
NOT_YET_RECRUITINGAmiens, 80054, France
-
Centre François Baclesse
NOT_YET_RECRUITINGCaen, 14076, France
-
Centre Oscar Lambret
RECRUITINGLille, 59020, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Tumor's genetic blueprint guide better treatment for kids with brain cancer?
- Can adding lenvatinib to standard care outsmart a tough brain cancer?
- Can a sharper beam of radiation shield the mind during brain tumor treatment?
- One dose may not fit all: blood tests could tailor cancer drug dosing
- Can a new 'Nanobody' tracer outsmart standard scans for neuroendocrine cancers?
- Can a Brain-Cancer drug take on a stubborn stomach tumor?